A detailed history of Lindbrook Capital, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 505 shares of WVE stock, worth $6,822. This represents 0.0% of its overall portfolio holdings.

Number of Shares
505
Previous 505 -0.0%
Holding current value
$6,822
Previous $2,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$4.38 - $6.48 $411 - $609
94 Added 22.87%
505 $2,000
Q2 2023

Jul 28, 2023

BUY
$3.51 - $4.69 $916 - $1,224
261 Added 174.0%
411 $1,000
Q1 2023

Apr 26, 2023

BUY
$3.58 - $6.3 $537 - $945
150 New
150 $0

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.17B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.